TriSalus Life Sciences (TLSI) Cash from Operations (QoQ) (2021 - 2026)
TriSalus Life Sciences (TLSI) Cash from Operations (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | TriSalus Life Sciences | 220.07 Mn | 163.52 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -160.87% |
| Dec 31, 2025 | 33.03% |
| Sep 30, 2025 | 49.33% |
| Jun 30, 2025 | -62.70% |
| Mar 31, 2025 | 21.17% |
| Dec 31, 2024 | 47.39% |
| Sep 30, 2024 | 19.18% |
| Jun 30, 2024 | -23.51% |
| Mar 31, 2024 | -18.42% |
| Dec 31, 2023 | 57.64% |
| Sep 30, 2023 | -134.54% |
| Jun 30, 2023 | 12.06% |
| Mar 31, 2023 | -26.39% |
| Dec 31, 2022 | 63.68% |
| Sep 30, 2022 | -3,183.87% |
| Jun 30, 2022 | -63.57% |
| Mar 31, 2022 | 37.44% |
| Dec 31, 2021 | -86.48% |
| Sep 30, 2021 | 24.90% |
| Jun 30, 2021 | -136.20% |